CA2351860A1 - Piperazine ethylamide derivatives with 5-ht1a receptor activity - Google Patents

Piperazine ethylamide derivatives with 5-ht1a receptor activity Download PDF

Info

Publication number
CA2351860A1
CA2351860A1 CA002351860A CA2351860A CA2351860A1 CA 2351860 A1 CA2351860 A1 CA 2351860A1 CA 002351860 A CA002351860 A CA 002351860A CA 2351860 A CA2351860 A CA 2351860A CA 2351860 A1 CA2351860 A1 CA 2351860A1
Authority
CA
Canada
Prior art keywords
compound
disorder
phenyl
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002351860A
Other languages
English (en)
French (fr)
Inventor
Yvette Latko Palmer
Michael Gerard Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth
Yvette Latko Palmer
Michael Gerard Kelly
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth, Yvette Latko Palmer, Michael Gerard Kelly, American Home Products Corporation filed Critical Wyeth
Publication of CA2351860A1 publication Critical patent/CA2351860A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
CA002351860A 1998-12-17 1999-12-16 Piperazine ethylamide derivatives with 5-ht1a receptor activity Abandoned CA2351860A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21333698A 1998-12-17 1998-12-17
US09/213,336 1998-12-17
PCT/US1999/029953 WO2000035892A1 (en) 1998-12-17 1999-12-16 Piperazine ethylamide derivatives with 5-ht1a receptor activity

Publications (1)

Publication Number Publication Date
CA2351860A1 true CA2351860A1 (en) 2000-06-22

Family

ID=22794714

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002351860A Abandoned CA2351860A1 (en) 1998-12-17 1999-12-16 Piperazine ethylamide derivatives with 5-ht1a receptor activity

Country Status (6)

Country Link
EP (1) EP1140882A1 (pt)
JP (1) JP2002532481A (pt)
AU (1) AU3124100A (pt)
BR (1) BR9916263A (pt)
CA (1) CA2351860A1 (pt)
WO (1) WO2000035892A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
WO2003099266A2 (en) 2002-05-23 2003-12-04 Abbott Laboratories Acetamides and benzamides that are useful in treating sexual dysfunction
WO2006072608A2 (en) * 2005-01-03 2006-07-13 Universitá Degli Studi Di Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895840A (en) * 1987-06-10 1990-01-23 A. H. Robins Company, Incorporated N-(aryl-,aryloxy-,arylthio-arylsulfinyl-and arylsulfonyl-)alkyl-N,N'-(or n'n')alkylaminoalkyl ureas and cyanoguanidines
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
CA2166100A1 (en) * 1993-06-23 1995-01-05 Richard A. Glennon Sigma receptor ligands and the use thereof
US6342498B1 (en) * 1997-10-22 2002-01-29 Eli Lilly And Company Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Dα antagonists

Also Published As

Publication number Publication date
WO2000035892A1 (en) 2000-06-22
JP2002532481A (ja) 2002-10-02
EP1140882A1 (en) 2001-10-10
AU3124100A (en) 2000-07-03
BR9916263A (pt) 2001-09-04

Similar Documents

Publication Publication Date Title
CA2655654C (en) New carbonylated (aza)cyclohexanes as dopamine d3 receptor ligands
US6239126B1 (en) Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
SK42693A3 (en) Indoline derivatives with amidic group
JP3054677B2 (ja) 第三級アルキル官能基化ピペラジン誘導体
HRP20030748A2 (en) Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
JP2013526489A (ja) １−［（４−ヒドロキシピペリジン−４−イル）メチル］ピリジン−２（１ｈ）−オン誘導体、その調製方法およびその使用
AU600376B2 (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
US6242448B1 (en) Trisubstituted-oxazole derivatives as serotonin ligands
JPH04217663A (ja) ４−アミノメチルピペリジン誘導体
US5486518A (en) 4-indolylpiperazinyl derivatives
US6503928B2 (en) Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives
US6376494B1 (en) Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US6255302B1 (en) 1,4-piperazine derivatives
CA2351860A1 (en) Piperazine ethylamide derivatives with 5-ht1a receptor activity
CA2351400A1 (en) Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
US6344458B1 (en) Piperazine ethylamide derivatives
DE60011241T2 (de) Neue diazol-derivate und ihre verwendung als serotonergische wirkstoffe
AU3123100A (en) 1,4-piperazine derivatives having 5ht1a receptor activity
CA2354061A1 (en) Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
JP2002538154A (ja) セロトニン作動活性を有するｎ−置換イミド誘導体
MXPA01006061A (es) Derivados de etilamida de piperazina con actividad del receptor 5-ht1a
JP2007530658A (ja) 神経変性障害を治療するためのイソオキサゾール−アミン化合物及びイソチアゾール−アミン化合物
JP2009526844A (ja) ピペラジン誘導体
MXPA01006065A (en) 1,4-piperazine derivatives having 5ht1a receptor activity
MXPA00010456A (es) Agentes serotonergicos

Legal Events

Date Code Title Description
FZDE Dead